Public Profile

Vertex Pharmaceuticals

Vertex Pharmaceuticals Incorporated, commonly known as Vertex, is a leading biotechnology company headquartered in the United States. Founded in 1989, Vertex has established itself as a pioneer in the development of transformative therapies for serious diseases, particularly in the field of cystic fibrosis. With major operational regions across North America and Europe, the company focuses on innovative drug discovery and development. Vertex is renowned for its unique portfolio of cystic fibrosis treatments, including Kalydeco, Orkambi, and Trikafta, which have significantly improved the quality of life for patients. The company’s commitment to research and development has positioned it as a market leader, achieving notable milestones such as the first approved therapy for the underlying cause of cystic fibrosis. Vertex continues to drive advancements in biotechnology, solidifying its reputation as a key player in the industry.

DitchCarbon Score

How does Vertex Pharmaceuticals's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

50

Industry Average

Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

24

Industry Benchmark

Vertex Pharmaceuticals's score of 50 is higher than 98% of the industry. This can give you a sense of how well the company is doing compared to its peers.

98%

Let us know if this data was useful to you

Vertex Pharmaceuticals's reported carbon emissions

In 2023, Vertex Pharmaceuticals reported total carbon emissions of approximately 488,800 kg CO2e from Scope 2 and 831,100 kg CO2e from Scope 1, alongside a significant Scope 3 emission total of about 474,129,000 kg CO2e. This brought their total Scope 1 and 2 emissions to around 13,198,000 kg CO2e. In 2022, the company recorded Scope 1 emissions of about 9,334,000 kg CO2e, Scope 2 emissions of approximately 4,285,000 kg CO2e, and Scope 3 emissions reaching about 249,816,000 kg CO2e, resulting in a total of around 13,620,000 kg CO2e for Scope 1 and 2. Vertex Pharmaceuticals has not disclosed specific reduction targets or initiatives as part of their climate commitments. However, they continue to monitor and report their emissions across all three scopes, indicating a commitment to transparency in their environmental impact. The company operates within the pharmaceutical industry, which is increasingly focusing on sustainability and reducing carbon footprints.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2018201920202021202220232024
Scope 1
-
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
Scope 2
-
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
Scope 3
-
-
000,000,000
-
000,000,000
000,000,000
000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Vertex Pharmaceuticals's primary industry is Research and development services (73), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Vertex Pharmaceuticals is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Vertex Pharmaceuticals is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Celanese

US
Chemicals nec
Updated 1 day ago

Clariant

CH
Chemical and fertilizer minerals, salt and other mining and quarrying products n.e.c.
Updated 1 day ago

Incyte

US
Health and social work services (85)
Updated 1 day ago

Wacker Chemie

DE
Chemicals nec
Updated 1 day ago

Crucell N.V.

NL
Health and social work services (85)
Updated 3 months ago
DitchCarbon Score

Lonza

CH
Furniture; other manufactured goods n.e.c. (36)
Updated 1 day ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers